Evidence map›Paper›PMID 35075754›Full record

ArticleAngewandte Chemie (International ed. in English)2022

Biosynthesis of Terpenoid-Pyrrolobenzoxazine Hybrid Natural Product CJ-12662.

Wei Cheng, Mengbin Chen, Masao Ohashi, Yi Tang

Open access · greenAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Wei ChengDepartment of Chemical and Biomolecular Engineering, University of California, Los Angeles, CA 90095, USA.
Mengbin ChenDepartment of Chemical and Biomolecular Engineering, University of California, Los Angeles, CA 90095, USA.
Masao OhashiDepartment of Chemical and Biomolecular Engineering, University of California, Los Angeles, CA 90095, USA.
Yi TangDepartment of Chemical and Biomolecular Engineering, University of California, Los Angeles, CA 90095, USA.ORCID 0000-0003-1597-0141
University of California, Los Angeles · USMerck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

MIRA: Enzymology and Self-Resistance of Natural Product BiosynthesisR35GM118056 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Yi Tang · 2016 to 2026
$6.1M
NIGMS NIH HHS R35 GM118056
6 · The paper itself

Abstract

The fungal natural product CJ-12662 is a structurally complex terpene-amino acid hybrid, and is a potent anthelmintic compound. The biosynthetic pathway of CJ-12662 is elucidated based on metabolite analysis from heterologous expression. We demonstrate the terpene portion is derived from successive P450-catalyzed oxidations of amorpha-4,11-diene, while three flavin-dependent enzymes are involved in morphing the esterified tryptophan into a chlorinated pyrrolobenzoxazine, utilizing a cascaded [1,2]-Meisenheimer rearrangement.

Indexed as

Alkyl and Aryl TransferasesBiological ProductsBenzoxazinesPyrrolesTerpenesAlkyl and Aryl TransferasesBenzoxazinesBiological ProductsCJ 12662PyrrolesTerpenes[1,2]-Meisenheimer RearrangementAmorpha-4,11-diene SynthaseFlavoenzymesFungal Natural ProductsPyrrolobenzoxazine

Identifiers

PMID35075754
PMCPMC8901528
OpenAlexW4207010769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.